Transcription factor EB is involved in autophagy-mediated chemoresistance to doxorubicin in human cancer cells

导出原文传递学术成果认领

作者单位 Department of Pharmacology and Laboratory of Aging and Nervous Diseases,Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases,Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases,College of Pharmaceutical Science,Soochow University,Suzhou 215123,China ^[1] Department of General Surgery,the First People's Hospital of Wu Jiang,Suzhou 215200,China ^[2]

关键词 transcription factor EB (TFEB)LoVo cells HeLa cells doxorubicin autophagy apoptosis chemotherapy resistance 3-methyladenine

栏目名称 Chemotherapy

DOI 10.1038/aps.2017.25

发布时间 2017-09-26

基金项目

the Jiangsu Provincial Commission of Health and Family Planning 2014 2015 (№ YG201503) as well as by Suzhou Wujiang District Science and Technology Bureau 2013

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0
被引1
下载0

中国药理学报（英文版）

2017年38卷9期

1305-1316页

SCIMEDLINEISTICCSCDCABP

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Transcription factor EB is involved in autophagy-mediated chemoresistance to doxorubicin in human cancer cells

中国药理学报（英文版）

相似文献

中国药理学报（英文版）

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Transcription factor EB is involved in autophagy-mediated chemoresistance to doxorubicin in human cancer cells

中国药理学报（英文版）

相似文献

中国药理学报（英文版）

相关期刊

检索历史清除